NewGenIVF Group announced a strong fiscal year 2025 with total assets reaching $32.7 million, up from $3.6 million the previous year, and a net profit of $9.9 million mainly due to gains from acquiring Nodexus and Microsort businesses. The company also completed a $17.9 million valuation of advanced cytometry intellectual property, contributing to a $19.2 million bargain purchase gain. NewGen is advancing its diversification strategy through digital assets and health supplements, supported by a $2 million share repurchase program reflecting management confidence. These results highlight NewGen's successful transformation and position it for continued growth across real estate, digital innovation, and healthcare sectors.
Dycom Industries reported a record first quarter with contract revenues up 56.1% to $1.965 billion and adjusted net income nearly doubling to $134.3 million. The company raised its full-year fiscal 2027 revenue outlook to $7.38-$7.65 billion, driven ...
BrewDog, part of Tilray Brands, is rolling out a major summer campaign across the UK tied to the global football tournament. The campaign features a "Win a Year of Beer" contest with special cans hidden in over 2.8 million packs at major retailers, p...
Atea Pharmaceuticals announced Phase 1 results indicating their Hepatitis C treatment regimen, combining bemnifosbuvir and ruzasvir, has a low risk of drug-drug interactions with common medications like omeprazole and rosuvastatin. This supports easi...
Girard Sharp LLP is investigating potential securities claims for former Discover investors who received Capital One shares after Capital One acquired Discover in May 2025. Since the merger, Capital One's stock price has declined, leading to possible...
Sunshine Silver, a mining and refining company based in Idaho, is preparing for a $2.32 billion initial public offering on the New York Stock Exchange. The company aims to raise up to $330 million by selling 20 million shares priced between $13.50 an...
